{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T01:21:56Z","timestamp":1788312116765,"version":"build-2803163510"},"reference-count":18,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Gilead Sciences, Janssen, Merck Sharp and Dohme"},{"DOI":"10.13039\/100010877","name":"ViiV Healthcare","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100010877","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Virology"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1016\/j.jcv.2019.04.009","type":"journal-article","created":{"date-parts":[[2019,5,3]],"date-time":"2019-05-03T11:41:50Z","timestamp":1556883710000},"page":"23-28","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Is the rate of virological failure to cART continuing to decline in recent calendar years?"],"prefix":"10.1016","volume":"116","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0375-9990","authenticated-orcid":false,"given":"Stefano","family":"Rusconi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria M","family":"Santoro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Gianotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Antinori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Bonora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonella","family":"Cingolani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Ceccherini Silberstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Tavelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonella","family":"d\u2019Arminio Monforte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Cozzi-Lepri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcv.2019.04.009_bib0005","doi-asserted-by":"crossref","first-page":"e87872","DOI":"10.1371\/journal.pone.0087872","article-title":"Expansion of HAART coverage is associated with sustained decreases in HIV\/AIDS morbidity, mortality and HIV transmission: the \"HIV Treatment as Prevention\" experience in a Canadian setting","volume":"9","author":"Montaner","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.jcv.2019.04.009_bib0010","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1056\/NEJMoa1105243","article-title":"HPTN 052 study team, prevention of HIV-1 infection with early antiretroviral therapy","volume":"365","author":"Cohen","year":"2011","journal-title":"N Engl. J. Med."},{"key":"10.1016\/j.jcv.2019.04.009_bib0015","first-page":"127","article-title":"Safety and tolerability: current challenges to antiretroviral therapy for the long-term management of HIV infection","volume":"18","author":"Troya","year":"2016","journal-title":"AIDS Rev."},{"key":"10.1016\/j.jcv.2019.04.009_bib0020","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1080\/09540121.2016.1189496","article-title":"Disparities in achieving and sustaining viral suppression among a large cohort of HIV-infected persons in care - Washington, DC","volume":"28","author":"Castel","year":"2016","journal-title":"AIDS Care"},{"key":"10.1016\/j.jcv.2019.04.009_bib0025","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1111\/j.1468-1293.2009.00816.x","article-title":"EuroSIDA study group, history of viral suppression on combination antiretroviral therapy as a predictor of virological failure after a treatment change","volume":"11","author":"Reekie","year":"2010","journal-title":"HIV Med."},{"key":"10.1016\/j.jcv.2019.04.009_bib0030","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1093\/cid\/cit529","article-title":"Virologic failure following persistent low-level viremia in a cohort of HIV-positive patients: results from 12 years of observation","volume":"57","author":"Laprise","year":"2013","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.jcv.2019.04.009_bib0035","doi-asserted-by":"crossref","first-page":"339","DOI":"10.2174\/1570162X12666140807151616","article-title":"Efficacy, tolerability and virological consequences of long-term use of unboosted atazanavir plus 2 NRTIs in HIV-infected patients","volume":"12","author":"Bonora","year":"2014","journal-title":"Curr. HIV Res."},{"key":"10.1016\/j.jcv.2019.04.009_bib0040","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1086\/650537","article-title":"Predicting virologic failure in an HIV clinic","volume":"50","author":"Robbins","year":"2010","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.jcv.2019.04.009_bib0045","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1080\/15284336.2016.1189754","article-title":"Characteristics associated with virologic failure in high-risk HIV-positive participants with prior failure: a post hoc analysis of ACTG 5251","volume":"17","author":"Robbins","year":"2016","journal-title":"HIV Clin. Trials"},{"key":"10.1016\/j.jcv.2019.04.009_bib0050","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1089\/apc.2014.0165","article-title":"Comparison of HIV virologic failure rates between patients with variable adherence to three antiretroviral regimen types","volume":"29","author":"Gordon","year":"2015","journal-title":"AIDS Patient Care STDS"},{"key":"10.1016\/j.jcv.2019.04.009_bib0055","doi-asserted-by":"crossref","first-page":"e3361","DOI":"10.1097\/MD.0000000000003361","article-title":"Adherence to antiretroviral therapy and virologic failure: a meta-analysis","volume":"95","author":"Bezabhe","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.jcv.2019.04.009_bib0060","doi-asserted-by":"crossref","first-page":"867","DOI":"10.3851\/IMP2531","article-title":"Impact of pre-therapy viral load on virological response to modern first-line HAART","volume":"18","author":"Santoro","year":"2013","journal-title":"Antivir. Ther. (Lond.)"},{"key":"10.1016\/j.jcv.2019.04.009_bib0065","doi-asserted-by":"crossref","first-page":"249","DOI":"10.3851\/IMP3197","article-title":"VIRO-immunological response of drug-naive HIV-1-infected patients starting a first-line regimen with viraemia &500,000 copies\/ml in clinical practice","volume":"23","author":"Santoro","year":"2018","journal-title":"Antivir. Ther. (Lond.)"},{"key":"10.1016\/j.jcv.2019.04.009_bib0070","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1002\/jmv.24017","article-title":"The role of baseline HIV-1 RNA, drug resistance, and regimen type as determinants of response to first-line antiretroviral therapy","volume":"86","author":"Di Biagio","year":"2014","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.jcv.2019.04.009_bib0075","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/S1473-3099(11)70032-9","article-title":"EuroCoord-CHAIN study group, effect of transmitted drug resistance on virological and immunological response to initial combination antiretroviral therapy for HIV (EuroCoord-CHAIN joint project): a European multicohort study","volume":"11","author":"Wittkop","year":"2011","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.jcv.2019.04.009_bib0080","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1097\/QAI.0000000000000942","article-title":"R.W. Shafer. Response to therapy in antiretroviral therapy-naive patients with isolated nonnucleoside reverse transcriptase inhibitor-associated transmitted drug resistance","volume":"72","author":"Clutter","year":"2016","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"10.1016\/j.jcv.2019.04.009_bib0085","first-page":"855","article-title":"Pre-existent NRTI and NNRTI resistance impacts on maintenance of virological suppression in HIV-1-infected patients who switch to a tenofovir\/emtricitabine\/rilpivirine single-tablet regimen","volume":"72","author":"Armenia","year":"2017","journal-title":"J. Antimicrob. Chemother."},{"issue":"July (20)","key":"10.1016\/j.jcv.2019.04.009_bib0090","article-title":"Human immunodeficiency virus drug resistance: 2018 recommendations of the international antiviral society-USA panel","author":"G\u00fcnthard","year":"2018","journal-title":"Clin. Infect. Dis."}],"container-title":["Journal of Clinical Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1386653219300976?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1386653219300976?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T03:11:52Z","timestamp":1761361912000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1386653219300976"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7]]},"references-count":18,"alternative-id":["S1386653219300976"],"URL":"https:\/\/doi.org\/10.1016\/j.jcv.2019.04.009","relation":{},"ISSN":["1386-6532"],"issn-type":[{"value":"1386-6532","type":"print"}],"subject":[],"published":{"date-parts":[[2019,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Is the rate of virological failure to cART continuing to decline in recent calendar years?","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Virology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcv.2019.04.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}